NCT06524336View on ClinicalTrials.gov

Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

October 28, 2024

Study Completion Date

October 28, 2024

Conditions
Malaria,Falciparum
Trial Locations (1)

Unknown

Moroto Hospital, Moroto

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Malaria Consortium

OTHER

NCT06524336 - Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children | Biotech Hunter | Biotech Hunter